BSE Live
Mar 02, 16:01Prev. Close
8842.60
Open Price
8399.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 02, 15:59Prev. Close
8849.00
Open Price
8352.00
Bid Price (Qty.)
8801.00 (10)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of AstraZeneca Pharma (in Rs. Cr.) | Dec 04 | |
| 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 43.69 | |
| Net CashFlow From Operating Activities | 49.30 | |
| Net Cash Used In Investing Activities | -5.94 | |
| Net Cash Used From Financing Activities | -2.20 | |
| Foreign Exchange Gains / Losses | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 41.15 | |
| Cash And Cash Equivalents Begin of Year | 30.07 | |
| Cash And Cash Equivalents End Of Year | 71.22 |
12.02.2026
01.02.2026
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
10.11.2025
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y